User Testing of an End of Life Medication Support Intervention for Lay Carers (Palliate).
NCT ID: NCT06526637
Last Updated: 2024-08-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
21 participants
INTERVENTIONAL
2024-08-31
2025-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The Palliate intervention is a nurse-led process that includes training and documentation materials to support lay carers in administering top up medications to loved ones at the end of life at home. The Palliate intervention was designed based on the CARiAD\* intervention using user testing and has been successfully piloted and rolled out in Central and North West London National Health Service (NHS) Foundation Trust.
\*CARer-ADministration of as-needed sub-cutaneous medication for breakthrough symptoms in homebased dying patients.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Translating Data Science to Palliative Care
NCT05942040
Identification of Elderly Patients in Need of Palliative Care by Family Physicians
NCT04010136
Palliative Care for Patients With Dementia
NCT05749146
Palliative Care at Home for Dementia
NCT03798327
Implementation of a Telehealth Palliative Care Model for Persons With Dementia
NCT05001620
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Version 1 of Palliate
Participants will be randomised to receive this version of Palliate training and materials.
Paper Package
Paper based (as per current practice at Central and North West London (CNWL) NHS Foundation Trust) version of Palliate.
Version 2 of Palliate
Participants will be randomised to receive this version of Palliate training and materials.
V1 + Preparation Sheet
Paper based version of Palliate plus a preparation sheet, that provides visual cues as to what equipment is required for the preparation and administration of the medications.
Version 3 of Palliate
Participants will be randomised to receive this version of Palliate training and materials.
V2 + Video Training
Hybrid - paper based materials, preparation sheet, and video instructions available via an interactive portable document format (PDF) version of the training materials.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Paper Package
Paper based (as per current practice at Central and North West London (CNWL) NHS Foundation Trust) version of Palliate.
V1 + Preparation Sheet
Paper based version of Palliate plus a preparation sheet, that provides visual cues as to what equipment is required for the preparation and administration of the medications.
V2 + Video Training
Hybrid - paper based materials, preparation sheet, and video instructions available via an interactive portable document format (PDF) version of the training materials.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Oak Foundation
OTHER
Imperial College London
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Leila Shepherd, PhD
Role: PRINCIPAL_INVESTIGATOR
Imperial College London
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Imperial College London
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OFIL-20-279
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.